You are here

Home

Treatments

Take whatever COVID vaccine you can get--EU drugs official

Wed, 2022-09-14 14:03 — mike kraft
Take whatever COVID vaccine you can get, says head of EU drugs watchdog FRANKFURT/LONDON (Reuters) -People in Europe should take whatever COVID-19 booster is available to them in the coming months, Emer Cooke, Executive Director of the European Medicines Agency (EMA), said in a Reuters Next Newsmaker interview, ahead of an expected autumn rise in infections. She said different countries across the bloc would likely have different autumn booster campaign timings and strategies, but it was important to remember the pandemic was not over and people should continue to prioritize getting protected.
Country / Region Tags: 
Europe
General Topic Tags: 
COVID-19
Treatments
Disease Prevention
Government
Pandemics
Public Health
Science
Problem, Solution, SitRep, or ?: 
Situation Report

China: Moderna open to supplying COVID vaccines to China, CEO says

Wed, 2022-09-14 13:20 — mike kraft
Moderna open to supplying COVID vaccines to China, CEO says Moderna Inc has held talks with the Chinese government about supplying COVID-19 vaccines, but no decision has yet been made, CEO Stephane Bancel told Reuters on Wednesday. Reuters Reuters
Country / Region Tags: 
China
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Health
Pandemics
Public Health
Vaccinations
Cooperation
Problem, Solution, SitRep, or ?: 
Situation Report

The Most Common Side Effects Of The New Bivalent COVID Booster

Tue, 2022-09-13 16:24 — mike kraft
The Most Common Side Effects Of The New Bivalent COVID Booster Here's what you can expect when you get the Pfizer or Moderna vaccine and how you can ease any symptoms. YahooNews

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Symptoms
Boosters
Treatments
Disease
Disease Prevention
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

International efforts to counter AIDS, TB and malaria bounced back post-COVID, but not enough--report

Tue, 2022-09-13 16:15 — mike kraft
Fight against AIDS, TB and malaria bounced back post-COVID - but not enough Efforts to tackle AIDS, tuberculosis and malaria began to recover last year after being hit hard by the COVID-19 pandemic in 2020, but the world is still not on track to defeat these killer diseases, according to a report. Jennifer Rigby Reuters

 

Country / Region Tags: 
Africa
Europe
Global
United Kingdom
United Nations
General Topic Tags: 
Treatments
Contagion
Disease
Disease Prevention
Government
Health
Hospitals
Pandemics
Public Health
Research
Science
Social behavior
Problem, Solution, SitRep, or ?: 
Analysis

EU regulator clears Pfizer-BioNTech’s tweaked COVID booster

Mon, 2022-09-12 16:43 — mike kraft
EU regulator clears Pfizer-BioNTech's tweaked COVID booster LONDON (AP) — The European Medicines Agency has recommended the authorization of a tweaked booster dose of the Pfizer-BioNTech coronavirus vaccine that includes protection against two of the latest versions of omicron, as countries look to bolster their immunization programs ahead of winter. AP NEWS

...

Country / Region Tags: 
Europe
Germany
Global
General Topic Tags: 
COVID-19
Boosters
Treatments
Contagion
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

U.S. starts enrollments in trial testing smaller dosage of monkeypox vaccine

Thu, 2022-09-08 21:31 — mike kraft

U.S. starts enrollments in trial testing smaller dosage of monkeypox vaccine

Reuters--

...

U.S. health regulators last month authorized injecting the shot intradermally in adults, meaning between layers of the skin rather than below the skin, in an effort to stretch out low vaccine supplies. read more

 

Country / Region Tags: 
Global
United States
General Topic Tags: 
Mpox
Treatments
Disease
Disease Prevention
Government
Health
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Omicron variant BA.4.6 evades protection of Evusheld's antibodies, study finds

Thu, 2022-09-08 21:23 — mike kraft
New Omicron offshoot BA.4.6 evades protection of Evusheld's antibodies, study finds The antibodies in Evusheld, the only therapy available to protect people with reduced immune function against Covid-19, may lose their punch against the BA.4.6 subvariant, a new study shows. Brenda Goodman, CNN CNN

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Pfizer isn’t sharing Covid vaccines with researchers for next-gen studies; Donates Paxlovid to poorer countries i

Wed, 2022-09-07 20:29 — mike kraft
Pfizer isn’t sharing Covid vaccines with researchers for next-gen studies Researchers studying next-gen vaccines to fight an evolving Covid threat are running into problems getting existing vaccines to use in their research. Rachel Cohrs STAT

WASHINGTON — Researchers studying next-generation vaccines to fight an evolving Covid-19 threat are running into problems getting existing vaccines to use in their research.

Country / Region Tags: 
Africa
Global
Latin America
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Disease
Disease Prevention
Health
Medical Testing
Mutations
Pandemics
Public Health
Research
Science
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Nasel spray vaccines might stop the coronavirus in its tracks, although there’s little evidence from human trials so far.

Wed, 2022-09-07 20:18 — mike kraft
China and India approve nasal COVID vaccines — are they a game changer? Nature - Scientists hope the immunizations, delivered through the nose or mouth, will prevent even mild cases of illness. Waltz, Emily nature

...

These mucosal vaccines target thin mucous membranes that line the nose, mouth and lungs. By prompting immune responses where SARS-CoV-2 first enters the body, mucosal vaccines could, in theory, prevent even mild cases of illness and block transmission to other people — something COVID-19 shots have been unable to do. Vaccines that produce sterilizing immunity would be game changing for the pandemic. ...

Country / Region Tags: 
China
Global
India
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Government
Health
Medical Testing
Pandemics
Public Health
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis
Situation Report

Israel reports it has isolated a coronavirus antibody in 'significant breakthrough

Wed, 2022-09-07 20:09 — mike kraft
Two antibodies identified in Israel can fight all known COVID strains, study finds Infusible to patients, antibodies are so powerful neutralizing the coronavirus they could eliminate the need for more vaccine boosters, peer-reviewed research says timesofisrael

...

The antibody reported as having been isolated at the IIBR is monoclonal, meaning it was derived from a single recovered cell and is thus potentially of more potent value in yielding a treatment.

...

Country / Region Tags: 
Global
Israel
General Topic Tags: 
COVID-19
Treatments
Disease
Disease Prevention
Government
Health
Medical Testing
Pandemics
Public Health
Research
Science
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Treatments
howdy folks
Page loaded in 1.040 seconds.